BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36186406)

  • 1. Peristomal granulation tissue mimicking peristomal pyoderma gangrenosum in the context of urine-diverting ostomies.
    McLarney BD; Huang S; Hsu S
    JAAD Case Rep; 2022 Nov; 29():33-36. PubMed ID: 36186406
    [No Abstract]   [Full Text] [Related]  

  • 2. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
    Funayama Y; Kumagai E; Takahashi K; Fukushima K; Sasaki I
    Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of peristomal pyoderma gangrenosum.
    Poritz LS; Lebo MA; Bobb AD; Ardell CM; Koltun WA
    J Am Coll Surg; 2008 Feb; 206(2):311-5. PubMed ID: 18222385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of peristomal pyoderma gangrenosum: A Single Center Retrospective Observational Study.
    Honma M; Sugawara M; Ueno N; Honma M; Hinooka R; Tani C
    J Dermatol; 2022 Nov; 49(11):1178-1182. PubMed ID: 35789032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of peristomal pyoderma gangrenosum.
    Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
    Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review.
    Afifi L; Sanchez IM; Wallace MM; Braswell SF; Ortega-Loayza AG; Shinkai K
    J Am Acad Dermatol; 2018 Jun; 78(6):1195-1204.e1. PubMed ID: 29288099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab for peristomal pyoderma gangrenosum.
    Mimouni D; Anhalt GJ; Kouba DJ; Nousari HC
    Br J Dermatol; 2003 Apr; 148(4):813-6. PubMed ID: 12752145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management.
    Sheldon DG; Sawchuk LL; Kozarek RA; Thirlby RC
    Arch Surg; 2000 May; 135(5):564-8; discussion 568-9. PubMed ID: 10807281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peristomal pyoderma gangrenosum and inflammatory bowel disease.
    Cairns BA; Herbst CA; Sartor BR; Briggaman RA; Koruda MJ
    Arch Surg; 1994 Jul; 129(7):769-72. PubMed ID: 7912923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical Management of Peristomal Pyoderma Gangrenosum: A Report of 3 Case Studies.
    Toyoda T; Mitsuyama S; Nagao E; Abe F; Kimura M; Seido Y; Higuchi T
    J Wound Ostomy Continence Nurs; 2021 Jul-Aug 01; 48(4):345-349. PubMed ID: 33951706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative and Peristomal Pyoderma Gangrenosum: Subtypes of Pyoderma Gangrenosum.
    Kipers T; Tolkachjov SN
    Dermatol Clin; 2024 Apr; 42(2):171-181. PubMed ID: 38423679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical treatment options for peristomal pyoderma gangrenosum.
    Vujnovich A
    Br J Nurs; 2005 Sep 8-21; 14(16):S4-8. PubMed ID: 16215501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum versus chronic venous ulceration: comparison of diagnostic features.
    Koo K; Brem H; Lebwohl M
    J Cutan Med Surg; 2006; 10(1):26-30. PubMed ID: 17241569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
    Wang J; Prenner J; Wang W; Sakuraba A; Hyman N; Dalal S; Hurst R; Cohen RD; Umanskiy K; Shogan BD; Alpert L; Rubin DT; Colwell J; Pekow J
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1365-1372. PubMed ID: 32383278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and treatment of peristomal pyoderma gangrenosum.
    Hughes AP; Jackson JM; Callen JP
    JAMA; 2000 Sep; 284(12):1546-8. PubMed ID: 11000649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013.
    Barbosa NS; Tolkachjov SN; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT; Bridges AG; Wetter DA
    J Am Acad Dermatol; 2016 Nov; 75(5):931-939. PubMed ID: 27473454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective management of peristomal pyoderma gangrenosum.
    Hanley J
    Br J Nurs; 2011 Apr 14-27; 20(7):S12, S14-7. PubMed ID: 21537269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pyoderma gangrenosum peristomal in ulcerative colitis; first report of a case in Mexico].
    Vergara-Fernández O; Vega R; Morales-Olivera JM; Gamboa-Domínguez A; Uscanga L; Takahashi-Monrroy T
    Rev Gastroenterol Mex; 2008; 73(2):89-92. PubMed ID: 19666253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe peristomal pyoderma gangrenosum: a case study.
    Brady E
    J Wound Ostomy Continence Nurs; 1999 Nov; 26(6):306-11. PubMed ID: 10865615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis.
    Behm K; Larson DW; Colibaseanu D
    J Surg Case Rep; 2015 Mar; 2015(3):. PubMed ID: 25802252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.